Faper Group
Faper Group is a privately held Italian holding company founded in 2001 that operates Futura S.p.A. (tissue paper converting machinery) and Cisa Group (hospital sterilization and infection control systems), serving global tissue manufacturers and healthcare facilities through direct enterprise sales across Italy, North America, and Latin America.
- Company typePrivate
- Founded2001
- HeadquartersViareggio, Italy
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Faper Group does
Faper Group S.p.A. is a privately held Italian holding company founded in 2001 by inventor Fabio Perini and headquartered in Viareggio, Italy. The group operates across two principal industrial verticals: high-performance tissue paper converting machinery through its core subsidiary Futura S.p.A., and sterilization and infection control systems for hospitals and life science industries through Cisa Group. Its product portfolio includes Futura's automated converting lines (Andromeda series, Create technology for nonwovens), Plusline's packaging solutions (Pluspack FBO units), and Cisa's healthcare sterilization equipment, supported by a network of wholly-owned entities in Italy, North America, and Latin America serving over 85 countries.
The underlying technology is rooted in decades of mechanical and process engineering IP. Fabio Perini invented the first automatic tissue paper cutting machine in 1960 and holds nearly 100 patents, with the group collectively holding 200+ patents and prototypes. Futura Lab functions as a dedicated R&D and engineering training center. The current generation of converting lines features automatic hot roll changeover in 20 minutes, offline web lamination at speeds up to 1,000 m/min, and ergonomic automation that reduces operational cost per ton. Futura reports approximately 50 million euros in annual turnover, 172 employees, and 116 production lines installed worldwide.
Faper Group generates revenue primarily through direct enterprise sales of capital equipment to tissue paper manufacturers and healthcare facilities, complemented by installation, service, and aftermarket support. Customer segments include global tissue manufacturers (Sofidel, Lucart, Essity, Wepa, Irving Consumer Products) and Italian healthcare facilities served by Cisa. The group operates through wholly-owned direct sales subsidiaries in Italy, the United States, and Latin America, supplemented by trade-show-driven lead generation (INDEX23, MIAC, AIIC). Pricing is quote-based and negotiated directly with enterprise customers. The group has actively rationalized its portfolio since 2008, divesting Toscotec, Milltech, Focus, Perini Navi, and Celtech Business Park while adding Plusline and Cisa Brasil.
Faper Group firmographics
Firmographics- Name
- Faper Group
- Legal name
- FAPER GROUP S.p.A.
- Website
- https://fapergroup.it
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Faper Group is a privately held Italian holding company founded in 2001 that operates Futura S.p.A. (tissue paper converting machinery) and Cisa Group (hospital sterilization and infection control systems), serving global tissue manufacturers and healthcare facilities through direct enterprise sales across Italy, North America, and Latin America.
- Ownership category
- akta.pro rank
Where Faper Group is headquartered
LocationHeadquarters
- HQ city
- Viareggio
- HQ country
- Italy
- HQ region
- Europe
Offices10 records
Markets served
Faper Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Tissue Converting Machinery Sales: Sale of high-performance converting lines and machines for tissue paper manufacturing. Includes Andromeda lines, Pluspack FBO units, and other converting equipment. Revenue generated from equipment sales, installation, and related services to tissue manufacturers worldwide.
- Sterilization and Infection Control Systems: Sale and service of sterilization and infection control systems for hospitals and life science industries through Cisa Group division.
- Advisory Services: Advisory services for development and real estate investments, supporting entrepreneurial initiatives.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels3 records
Faper Group product offering
Product offeringCore offering
Faper Group S.p.A. is an Italian industrial holding company that designs, manufactures, and sells high-performance tissue paper converting machinery and packaging equipment through its subsidiary Futura S.p.A. (including the Andromeda and Create converting lines and Pluspack FBO units), and provides sterilization and infection control systems for hospitals and life science industries through its subsidiary Cisa Group. The group sells equipment and integrated solutions directly to industrial tissue manufacturers and to healthcare facilities, supported by an installed base of 116 production lines across more than 85 countries.
Product overview
Faper Group is a holding company founded in 2001 by Fabio Perini, focused on two core activities: high-performance solutions for tissue paper converting and sterilization/infection control systems for hospitals. The group's product portfolio includes Futura S.p.A. (tissue converting machinery including Andromeda and Create lines), Cisa Group (medical infection control systems), Plusline (packaging solutions acquired by Futura), and Perini Business Park (real estate advisory in Brazil). Futura serves as the core converting technology business with 172 employees, 116 production lines installed worldwide, and approximately 50 million euros in annual turnover. The group operates across Italy, the United States, and Latin America, providing local service and support in over 85 countries.
Differentiator
Problem solved
Functional benefit
Products and services
- Andromeda Tissue Converting Line High-automation tissue converting production line developed by Futura S.p.A., with Andromeda 3 being the latest generation redefining quality, efficiency, ergonomics, and safety in tissue converting.
- Create Nonwoven Converting Solution Innovative converting solution for the nonwoven sector developed by Futura S.p.A., enabling process automation, product quality, safety, and operational flexibility for hygiene and medical nonwoven manufacturers.
- Pluspack FBO Packaging Unit State-of-the-art Fold Box Over packaging unit developed by Plusline for tissue packaging, designed for extraordinary adaptability to specific customer needs; purchased by customers including Irving Consumer Products.
- Cisa Group Sterilization and Infection Control Systems Sterilization and infection control systems sold by Cisa Group to hospitals, healthcare facilities, and life science industries, focused on reducing waste, cutting costs, and supporting environmental sustainability.
Quantifiable outcome
- 116 production lines installed worldwide
- +4 more outcomes
Companies that use Faper Group
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles2 records
Faper Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Faper Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Visualize IT S.r.l.minorFaper Group held a 49% partnership stake in Visualize IT S.r.l., a startup focused on innovation. The partnership provided financial support and organizational guidance. The startup successfully completed validation and early scaling-up phases, after which Faper Group divested its minority shareholding to next phase partners.
Scale indicators7 records
Recent moves13 records
Expansion highlights6 records
Faper Group competitors and assessment
Company assessmentBroad incumbents
- Andritz: Austrian pulp, paper, and tissue machinery giant (multi-billion revenue). Operates broadly across the same tissue-converting space as Faper but as part of a much larger industrial portfolio; competes in large-scale tissue lines that often include Futura-grade converting equipment.
- Getinge: Swedish-listed provider of hospital sterilization, disinfection, and infection control solutions for life sciences and healthcare. Direct competitor to Cisa's infection-control offering, with broader geographic reach and product breadth.
- STERIS: Multi-billion-dollar US-listed leader in hospital sterilization and infection prevention. Comparable to Cisa Group as a sterilization/infection-control incumbent, but at vastly greater scale and global hospital installed base.
- 3M Health Care: Global healthcare conglomerate with major infection-prevention and sterilization-adjacent product portfolios. Overlaps with Cisa's hospital-focused infection-control mission at vastly greater scale, defining competitive benchmark rather than head-to-head rivalry.
- Valmet: Finnish global leader in pulp, paper, and tissue machinery and automation. Much larger incumbent with overlapping tissue-converting scope; reference benchmark for the segment in which Futura competes.
Direct peers
- Toscotec: Italian-headquartered manufacturer of tissue and paper converting machinery that was formerly part of Faper (divested 2008). Direct competitor serving the same tier-1 tissue converters (Sofidel, Essity, Lucart) with overlapping product lines, including towel and tissue converting systems.
- BW Papersystems: Specialty machinery builder for tissue, paper, and packaging converting headquartered in the US/EU. Comparable to Futura's converting and Plusline's packaging product families, serving many of the same global converters.
- PCMC (Paper Converting Machine Company): US-based manufacturer of converting machinery for tissue, nonwovens, and packaging, including rewinders and embossing units. Comparable peer because it competes head-to-head with Futura/Plusline in tissue converting and packaging lines.
- A.Celli Group: Italian tissue and nonwovens converting machinery specialist headquartered near Lucca, supplying complete turnkey lines (winders, rewinders, packaging) to global tissue makers. Directly comparable to Futura's Andromeda/Pluspack stack in product, geography, and customer base.
- Körber Tissue (Körber Business Area Tissue): German engineering group's tissue division supplies complete converting lines, packaging, and digital solutions to global tissue producers (Sofidel, Kimberly-Clark, etc.). Overlaps directly with Faper's combined Futura (converting) plus Plusline (packaging) offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Faper Group social profiles
Digital presenceFaper Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Faper Group leadership team
Management profileNumber of profiles
Profiles8 records
Faper Group subsidiaries and ownership
Company hierarchySubsidiaries10 records
Faper Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Faper Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Faper Group
What does Faper Group do?
Faper Group S.p.A. is an Italian industrial holding company that designs, manufactures, and sells high-performance tissue paper converting machinery and packaging equipment through its subsidiary Futura S.p.A. (including the Andromeda and Create converting lines and Pluspack FBO units), and provides sterilization and infection control systems for hospitals and life science industries through its subsidiary Cisa Group. The group sells equipment and integrated solutions directly to industrial tissue manufacturers and to healthcare facilities, supported by an installed base of 116 production lines across more than 85 countries.
Is Faper Group a public or private company?
Faper Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Faper Group founded?
Faper Group was founded in 2001. It employs 1 to 10 people.
Where is Faper Group based?
Faper Group is headquartered in Viareggio, Italy, in the Europe region.
How does Faper Group make money?
Three revenue lines are on record. Tissue Converting Machinery Sales are the primary driver. The others are sterilization and Infection Control Systems and advisory Services.
Who are Faper Group's main competitors?
Broad incumbents on record are Andritz, Getinge, STERIS, 3M Health Care and Valmet. Direct peers are Toscotec, BW Papersystems, PCMC (Paper Converting Machine Company), A.Celli Group and Körber Tissue (Körber Business Area Tissue).
Does Faper Group have an API?
No public API is recorded for Faper Group.